allantoin
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT06170346 | Nov 2022 → Jul 2023 | — | Padjadjaran University | Completed | No outcome recorded |
| Phase 2 | NCT02090283 | Mar 2014 → Sep 2018 | epidermolysis bullosa | Scioderm, Inc. | Terminated | No outcome recorded |
| Phase 2 | NCT00825565 | Feb 2009 → Nov 2010 | epidermolysis bullosa | Northwestern University | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT02670330 | Jun 2015 → Sep 2018 | epidermolysis bullosa | Scioderm, Inc. | Terminated | No outcome recorded |
| Phase 3 | NCT02384460 | Mar 2015 → Jul 2017 | epidermolysis bullosa | Scioderm, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01863407 | Apr 2013 → Nov 2014 | ileus | Beijing Bozhiyin T&S Co., Ltd. | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT04101890 | Mar 2020 → Jan 2021 | dermatitis | Linda Fu | Terminated | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07482813 Comparator | Jul 2026 → Jul 2027 expected | epidermolysis bullosa | Paradigm Therapeutics | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07482787 Comparator | May 2026 → May 2027 expected | epidermolysis bullosa | Paradigm Therapeutics | Not yet recruiting | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | allantoin | “30 drops of topical antioxidants (Gluconolactone 4%, Hyaluronic acid 0,01%, Allantoin 0,1%, Ferulic acid 3%, Acetyl heptapeptide 0,001%, Silver vine extract 1%, Ectoine 0,01%,...” NCT06170346 ↗8“Theraworx Foam Formulation-Allantoin Liquid by Avadim Technologies, Inc. is a skin protectant with use for temporary protection of minor cuts, scrapes, burns and chapped or...” NCT04101890 ↗ “SD-101 6% is a topical cream containing 6% allantoin that was developed for treating skin lesions in patients with EB.” PMID 32576219 ↗ Jun 2020 “SD-101-6.0 cream contains allantoin, a diureide glyoxylic acid, at a concentration of 6% and other excipients.” NCT02670330 ↗ “SD-101-6.0 cream contains allantoin, a diureide glyoxylic acid, at a concentration of 6% and other excipients.” NCT02090283 ↗ “SD-101-6.0 cream contains allantoin, a diureide glyoxylic acid, at a concentration of 6% and other excipients.” NCT07482787 ↗ “SD-101-6.0 cream contains allantoin, a diureide glyoxylic acid, at a concentration of 6% and other excipients.” NCT07482813 ↗ “Study of Dexamethasone-Allantoin-Metronidazole (DAM) Solution in the Treatment of Post-Operative Ileus (POI)” NCT01863407 ↗ “Alwextin cream contains active ingredient, allantoin 3%.” NCT00825565 ↗ |
| Known as | Alwextin | ChEMBL registry synonym — accepted as the source's own label CHEMBL593429 ↗ |
| Known as | Cordianine | ChEMBL registry synonym — accepted as the source's own label CHEMBL593429 ↗ |
| Known as | Dl-allantoin | ChEMBL registry synonym — accepted as the source's own label CHEMBL593429 ↗ |
| Known as | Idelalisib metabolite m1a | ChEMBL registry synonym — accepted as the source's own label CHEMBL593429 ↗ |
| Known as | NSC-7606 | ChEMBL registry synonym — accepted as the source's own label CHEMBL593429 ↗ |
| Known as | Psoralon | ChEMBL registry synonym — accepted as the source's own label CHEMBL593429 ↗ |
| Known as | Sd 101 | ChEMBL registry synonym — accepted as the source's own label CHEMBL593429 ↗ |
| Known as | Septalan | ChEMBL registry synonym — accepted as the source's own label CHEMBL593429 ↗ |
| Modality | Small molecule | — CHEMBL593429 ↗ |
| Route | Topical | “Allantoin 3% cream is applied topically to the entire body once daily.” NCT00825565 ↗ |